Yellow fever vaccine-associated viscerotropic disease: Difference between revisions
From IDWiki
(Created page with "== Background == === Risk Factors === * Risk increases with age > 60 years * Thymus disease (thymoma, myasthenia gravis, thymectomy) == Clinical Manifestations == * Incuba...") |
(categories) |
||
| Line 1: | Line 1: | ||
== |
==Background== |
||
=== |
===Risk Factors=== |
||
* |
*Risk increases with age > 60 years |
||
* |
*Thymus disease (thymoma, myasthenia gravis, thymectomy) |
||
== |
==Clinical Manifestations== |
||
* |
*Incubation period [[Usual incubation period::2 to 5 days]] |
||
* |
*Characterized by multiorgan failure similar to [[yellow fever]] |
||
* |
*High mortality 65%, higher in women |
||
[[Category:Infectious diseases]] |
|||
[[Category:Vaccination]] |
|||
Latest revision as of 20:55, 10 August 2020
Background
Risk Factors
- Risk increases with age > 60 years
- Thymus disease (thymoma, myasthenia gravis, thymectomy)
Clinical Manifestations
- Incubation period 2 to 5 days
- Characterized by multiorgan failure similar to yellow fever
- High mortality 65%, higher in women
